House Health Care & Wellness
House Health Care and Wellness Committee · February 10, 2026
The House Health Care and Wellness Committee met Feb. 10 to hear two bills: Gross Second Substitute Senate Bill 5,594 on pharmacist substitution of biosimilars and Senate Bill 5,124 on Medicaid network adequacy for post-acute care. Supporters cited cost savings; patient advocates raised point-of-sale implementation and out-of-pocket cost concerns.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.
